bluebird bio (BLUE) IPO Opens Sharply Higher Jun 19, 2013 10:28AM

The IPO for bluebird bio (Nasdaq: BLUE) opened for trading at $25.50 after pricing at $17, above the expected $14-$16 range. The company sold 5.9 million shares in the IPO, raising just over $100 million. The IPO size was raised from 5 million shares.

J.P. Morgan and BofA Merrill Lynch are leading the IPO.

bluebird bio is a clinical-stage biotechnology company focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy.

bluebird bio and its scientific collaborators have generated what they believe is human proof-of-concept data for their gene therapy platform in two underserved diseases, each of which has been granted orphan drug status by U.S. and European regulatory authorities. They expect to initiate in late 2013 a Phase II/III clinical study of their most advanced product candidate, Lenti-D, to evaluate its safety and efficacy in subjects with childhood cerebral adrenoleukodystrophy, or CCALD, a rare, hereditary neurological disorder affecting young boys that is often fatal. They also expect to initiate in mid-2013 Phase I/II clinical studies in the United States and Europe of their next most advanced product candidate, LentiGlobin, to evaluate its safety and efficacy in subjects with ß-thalassemia major and, in the European clinical study, sickle cell disease, or SCD, which are rare, hereditary blood disorders that often lead to severe anemia and shortened lifespans. In addition, in March 2013, the company announced a global strategic collaboration with Celgene Corporation (Nasdaq: CELG) to discover, develop and commercialize novel, disease-altering gene therapies in oncology.


Iroko Pharma (IRKO Files $145M IPO Jun 19, 2013 08:12AM

Iroko Pharmaceuticals, Inc. (Nasdaq: IRKO) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering price is $145 million. The company plans to list on the Nasdaq Global Select Market under the ticker, "IRKO."

The offering is being made via Jefferies, William Blair, and Canaccord Genuity.

Iroko Pharmaceuticals is a global, specialty pharmaceutical company focused on the development and commercialization of novel nonsteroidal anti-inflammatory drug, or NSAID, therapeutics for patients with mild to moderate acute and chronic pain.


Elon Musk Says SpaceX Won't IPO Until Mars is a Reality Jun 18, 2013 05:43PM

Tesla (NASDAQ: TSLA) CEO Elon Musk said he won't take SpaceX public until they are ready to take people to Mars. Comments were made in a Reuters Insider interview Tuesday evening.

The comments reiterated an tweet on June 6th from the entrepreneur. "No near term plans to IPO @SpaceX. Only possible in very long term when Mars Colonial Transporter is flying regularly," Musk said.

Explaining the rational for not going the IPO route at this time, Musk said developing technology to go to Mars will take "years." This doesn't bode well for the patience of the typical Wall Street investor, he said, who are very short-term in nature.

Musk said SpaceX has been cash flow positive for 5 years, but would be much more profitable if they weren't developing the Mars technology. Going to Mars is the ultimate goal he said.


Loeb Boosts Sony (SNE) Stake, Continues Urging IPO on Entertainment Unit Jun 18, 2013 06:44AM

Sony (NYSE: SNE) is flat in early trading Tuesday amid reports that Dan Loeb's Third Point boosted its stake.

Loeb sent a letter to Sony CEO Kazuo Hirai stating that the electronics giant should move to partially spin-off its entertainment arm. He also offered to put a rep on Sony's board.

An IPO of the profitable unit could boost Sony's share price to $60, up from a close at $20.72 on Monday.

The stake was increased to 70 million shares, or roughly 7 percent of all outstanding at the company. Loeb previously disclosed a 64 million share stake. In total, Third Point has 46 million ordinary shares valued at $944 million and 24 million shares at $492 million attained through cash-settled swaps.


OCI Partners (OCIP) Files $480M IPO Jun 17, 2013 09:56AM

OCI Partners LP (NYSE: OCIP) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Units. The proposed maximum offering price is $480 million. The company plans to list on the New York Stock Exchange under the symbol “OCIP."

The offering is being made through BofA Merrill Lynch, Barclays, and Citigroup.

Financial summary: "We acquired our facility (which had been idled by the previous owners since 2004) in May 2011, commenced an upgrade that was completed in July 2012 and began operating our facility at full capacity in the fourth quarter of 2012. Our newly renovated facility began ammonia production in December 2011 and began methanol production in July 2012 (with no significant methanol production until August 2012), with revenues first generated from ammonia sales in the first quarter of 2012 and from methanol sales in the third quarter of 2012. For the three months ended March 31, 2013, our net income and EBITDA, on a pro forma basis, were approximately $56.5 million and $65.2 million, respectively. Subject to certain assumptions, we expect our net income and EBITDA to be approximately $167.3 million and $201.8 million, respectively, for the twelve months ending June 30, 2014."

OCI Partners is a Delaware limited partnership formed in February 2013 to own and operate a recently upgraded, integrated methanol and ammonia production facility that is strategically located on the Texas Gulf Coast near Beaumont.


More IPOs

View Older Stories

Jun 17, 2013 09:03AM Onconova Therapeutics (ONTX) Files $75M IPO
Jun 14, 2013 11:06AM A Sale or an IPO for Nokia Siemens Networks? (NOK)
Jun 14, 2013 07:31AM Envision Healthcare (EVH) Files $100M IPO
Jun 14, 2013 06:45AM Diamond Resorts Int'l (DRII) Files $200M IPO
Jun 14, 2013 06:27AM CDW Corp (CDW) Commences IPO; Will Sell 27.9M Common Shares
Jun 13, 2013 10:05AM Gigamon (GIMO) Takes a Breather
Jun 13, 2013 09:51AM Coty (COTY) IPO Opens Flat
Jun 13, 2013 09:26AM Russia's Lenta Said to Select Bankers for Massive IPO - Reuters
Jun 13, 2013 09:12AM HD Supply (HDS) Commences 53.2M IPO
Jun 13, 2013 06:33AM Coty (COTY) Prices 57.1M IPO at $17.50/Share
Jun 12, 2013 05:05PM GDC Technology (GDCT) Sees IPO Price of $12 - $14/ADS
Jun 12, 2013 11:27AM Wall Street Has Mixed Feelings on Coty, Inc. (COTY) Ahead of IPO Pricing
Jun 12, 2013 10:02AM Gigamon (GIMO) Peers on Watch Following Strong IPO (JNPR) (BRCD) (EXTR)
Jun 12, 2013 09:54AM Gigamon (GIMO) IPO Opens 21% Higher
Jun 12, 2013 09:47AM Gigamon (GIMO) IPO Indicated to Open Higher
Jun 12, 2013 09:00AM Luxoft Holding (LXFT) Commences 4.09M Common IPO
Jun 11, 2013 09:41AM IPO of Nokia Siemens Best Outcome for Nokia (NOK) - Credit Suisse
Jun 10, 2013 05:01PM Agios (AGIO) Files $86M IPO
Jun 10, 2013 11:28AM Brookfield Renewable (BEP) Files $500M U.S. Units Listing
Jun 7, 2013 10:12AM LightInTheBox (LITB) IPO Sees Follow-Through
Jun 7, 2013 09:51AM Textura Corporation (TXTR) IPO Rips Higher
Jun 7, 2013 06:34AM NRG Energy's NRG Yield (NYLD) Files $400M IPO
Jun 6, 2013 04:39PM LightInTheBox (LITB) IPO Lights-Up Wall Street
Jun 6, 2013 09:23AM Volaris Aviation Holding (VLRS) Files $100M IPO
Jun 6, 2013 09:03AM Devon Energy (DVN) To Form Publicly Traded MLP
Jun 5, 2013 08:53AM Athlon Energy (ATHL) Files $345M IPO
Jun 5, 2013 08:45AM Colony American Homes (CAHS) Pauses IPO Plans as REIT Market Cools
Jun 4, 2013 06:34AM QIWI plc (QIWI) Improves Q1 Results; Guides FY13 Growth
Jun 3, 2013 04:41PM Cellular Dynamics Int'l (ICEL) Files $57.25M IPO
Jun 3, 2013 03:00PM Tecogen (TGEN) Files $25M IPO
Jun 3, 2013 07:06AM Jefferies Starts American Residential Properties (ARPI) at Hold
Jun 3, 2013 06:58AM Jefferies Starts Cyan, Inc. (CYNI) at Buy
May 30, 2013 03:24PM Grupo Aval (AVAL) Files $100M IPO
May 29, 2013 11:59AM U.S. SEC Charges Nasdaq (NDAQ) for Botched Facebook (FB) IPO
May 29, 2013 11:57AM Iconic Empire State Building Receives Shareholder Support for IPO
May 28, 2013 05:18PM Jones Energy, Inc. (JONE) Files $250M IPO
May 28, 2013 08:21AM WCI Communities (WCIC) Files $150M IPO
May 28, 2013 08:12AM Oculus (OCLS) Submits Draft for IPO of Ruthigen, Inc.
May 24, 2013 02:30PM Evoke Pharma (EVOK) Files $24M IPO
May 24, 2013 12:23PM Channeladvisor (ECOM) Takes Breather after Rip Roaring IPO Debut
May 23, 2013 05:43PM Tremor Video (TRMR) Files $86.25M IPO
May 23, 2013 10:04AM ChannelAdvisor (ECOM) IPO Rips Higher
May 23, 2013 09:58AM Global Brass and Copper (BRSS) IPO Opens Higher
May 23, 2013 09:50AM Constellium (CSTM) IPO Opens Lower
May 23, 2013 09:43AM Ply Gem (PGEM) IPO Opens Higher
May 23, 2013 09:43AM ChannelAdvisor (ECOM) Prices 5.75M IPO at $14/Share
May 23, 2013 09:31AM KKR & Co. Might Push for Neiman Marcus, Saks (SKS) Merger
May 23, 2013 07:06AM GDC Technology (GDCT) Files $75M IPO
May 23, 2013 06:42AM Noodles & Co. Files (NDLS) Files $75M IPO
May 22, 2013 04:05PM Seaworld Ent. (SEAS) Narrows Q1 Loss to 49c/Share; Guides FY13 Revs
View Older Stories